Tianyu Jiao

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

Wenwen Zhang, Shuang Tong, Bingyang Hu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 126 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis

Yinbiao Cao, Haowen Tang, Bingyang Hu et al. · HPB · 2023 · 19 citations · Full text

Medicine, Oncology, Surgery +14

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature

Ze Zhang, Jin Shang, Bingyang Hu et al. · Frontiers in Immunology · 2022 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17

Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma

Ze Zhang, Tianyu Jiao, Junfeng Li et al. · World Journal of Surgical Oncology · 2023 · 12 citations · Full text

Medicine, Oncology, Surgery +16

Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma

Hao Jiang, Biao Gao, Zihe Meng et al. · Journal of Translational Medicine · 2024 · 10 citations · Full text

Medicine, Immunology, Oncology +17